• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
MGZ
Click for more information
0.00% 2.0¢

MEDIGARD LIMITED - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
MGZ Full Year Statutory Accounts29/09/14
MGZ Preliminary Final ReportPRICE SENSITIVE29/08/14
MGZ Convertible Note DeedPRICE SENSITIVE31/07/14
MGZ Appendix 4C - quarterlyPRICE SENSITIVE30/07/14
MGZAppendix 4C - quarterlyPRICE SENSITIVE30/04/14
MGZHalf Yearly Report and AccountsPRICE SENSITIVE28/02/14
MGZAppendix 4C - quarterlyPRICE SENSITIVE30/01/14
MGZChairman's Address to Shareholders20/11/13
MGZResults of Meeting20/11/13
MGZAppendix 4C - quarterlyPRICE SENSITIVE21/10/13
MGZAnnual Report to shareholders18/10/13
MGZNotice of Annual General Meeting/Proxy Form18/10/13
MGZFull Year Statutory Accounts24/09/13
MGZPreliminary Final ReportPRICE SENSITIVE28/08/13
MGZAppendix 4C - quarterlyPRICE SENSITIVE04/07/13
MGZDirector Appointment/Resignation06/06/13
MGZChange of Director's Interest Notice28/05/13
MGZAppendix 4C - quarterlyPRICE SENSITIVE18/04/13
MGZAppendix 3Y11/04/13
MGZChange of Director's Interest Notice27/03/13
MGZHalf Yearly Report and AccountsPRICE SENSITIVE28/02/13
MGZAppendix 4C - quarterlyPRICE SENSITIVE10/01/13
MGZResults of Meeting30/11/12
MGZChairman's Address to Shareholders30/11/12
MGZAnnual Report to shareholders30/10/12
MGZNotice of Annual General Meeting/Proxy Form30/10/12
MGZAppendix 4C - quarterlyPRICE SENSITIVE29/10/12
MGZMedigard announces Heads of AgreementPRICE SENSITIVE24/10/12
MGZFull Year Statutory Accounts13/09/12
MGZPreliminary Final ReportPRICE SENSITIVE28/08/12
MGZAppendix 4C - quarterlyPRICE SENSITIVE30/07/12
MGZAppendix 4C - quarterlyPRICE SENSITIVE30/04/12
MGZHalf Yearly Report and AccountsPRICE SENSITIVE29/02/12
MGZAppendix 4C - quarterlyPRICE SENSITIVE30/01/12
MGZResults of Meeting21/11/11
MGZChairman's Address to Shareholders21/11/11
MGZAppendix 4C - quarterlyPRICE SENSITIVE25/10/11
MGZNotice of Annual General Meeting/Proxy Form21/10/11
MGZAnnual Report to shareholders21/10/11
MGZAnnual Report to shareholders28/09/11
MGZPreliminary Final ReportPRICE SENSITIVE31/08/11
MGZAppendix 4C - quarterlyPRICE SENSITIVE29/07/11
MGZExpiry of Options03/06/11
MGZAppendix 4C - 31 March 2011PRICE SENSITIVE29/04/11
MGZResignation as Executive of Medigard18/04/11
MGZCompany Secretary Appointment/Resignation23/03/11
MGZAppendix 3B02/03/11
MGZNotice of Resignation CEO and Company SecretaryPRICE SENSITIVE24/02/11
MGZHalf Yearly Report and AccountsPRICE SENSITIVE24/02/11
MGZBoardroom Radio Broadcast02/02/11
MGZGrant of Japanese Patent (BCD) and IPRP (1mL Syringe)PRICE SENSITIVE01/02/11
MGZAppendix 4C - quarterlyPRICE SENSITIVE28/01/11
MGZUpdated Trading Policy31/12/10
MGZMEDIGARD CHANGE OF ADDRESS20/12/10
MGZTrading Policy07/12/10
MGZBoardroom Radio Broadcast24/11/10
MGZResults of Meeting24/11/10
MGZChairman's Address to Shareholders23/11/10
MGZChange of Director's Interest Notice16/11/10
MGZAppendix 3B16/11/10
MGZAppendix 4C - quarterlyPRICE SENSITIVE28/10/10
MGZAppendix 3B19/10/10
MGZNotice of Annual General Meeting/Proxy Form13/10/10
MGZAnnual Report to shareholders30/09/10
MGZGrant of Patent in South AfricaPRICE SENSITIVE21/09/10
MGZAppendix 3B13/09/10
MGZChange of Director's Interest Notice02/09/10
MGZChange of Director's Interest Notice02/09/10
MGZPreliminary Final ReportPRICE SENSITIVE31/08/10
MGZCompletion Renounceable Rights Issue and Appendix 3B30/08/10
MGZBoardroom Radio Broadcast20/08/10
MGZBroker Presentation17/08/10
MGZInvestor Presentations12/08/10
MGZDespatch of Prospectus and Letter to Shareholders10/08/10
MGZLetter to Shareholders09/08/10
MGZSupplementary Prospectus06/08/10
MGZMarket AnnouncementPRICE SENSITIVE05/08/10
MGZBoardroom Radio Broadcast03/08/10
MGZAppendix 4C - quarterlyPRICE SENSITIVE29/07/10
MGZLetter to Shareholders28/07/10
MGZRevised Indicative Timetable for Renounceable Rights Issue27/07/10
MGZProspectusPRICE SENSITIVE27/07/10
MGZRenounceable IssuePRICE SENSITIVE27/07/10
MGZLetter to Shareholders28/05/10
MGZSigning of US Manufacturing and Distribution AgreementsPRICE SENSITIVE26/05/10
MGZTrading HaltPRICE SENSITIVE25/05/10
MGZAppendix 4C - quarterlyPRICE SENSITIVE16/04/10
MGZAppendix 3B08/04/10
MGZClinical Trial Results USA - Medigard SyringePRICE SENSITIVE06/04/10
MGZAppendix 3B26/03/10
MGZReplacement and Updated Appendix 3B25/03/10
MGZMarketing and Product Evaluation USAPRICE SENSITIVE24/03/10
MGZAppendix 3B16/03/10
MGZAppendix 3B26/02/10
MGZHalf Yearly Report and AccountsPRICE SENSITIVE26/02/10
MGZChange of Director's Interest Notice12/02/10
MGZAppendix 4C - quarterlyPRICE SENSITIVE25/01/10
MGZMedigard Signs US ManufacturerPRICE SENSITIVE11/12/09
MGZResults of Meeting26/11/09
MGZChairman's Address to Shareholders25/11/09
MGZ Full Year Statutory Accounts
29/09/14
MGZ Preliminary Final Report
29/08/14PRICE SENSITIVE
MGZ Convertible Note Deed
31/07/14PRICE SENSITIVE
MGZ Appendix 4C - quarterly
30/07/14PRICE SENSITIVE
MGZAppendix 4C - quarterly
30/04/14PRICE SENSITIVE
MGZHalf Yearly Report and Accounts
28/02/14PRICE SENSITIVE
MGZAppendix 4C - quarterly
30/01/14PRICE SENSITIVE
MGZChairman's Address to Shareholders
20/11/13
MGZResults of Meeting
20/11/13
MGZAppendix 4C - quarterly
21/10/13PRICE SENSITIVE
MGZAnnual Report to shareholders
18/10/13
MGZNotice of Annual General Meeting/Proxy Form
18/10/13
MGZFull Year Statutory Accounts
24/09/13
MGZPreliminary Final Report
28/08/13PRICE SENSITIVE
MGZAppendix 4C - quarterly
04/07/13PRICE SENSITIVE
MGZDirector Appointment/Resignation
06/06/13
MGZChange of Director's Interest Notice
28/05/13
MGZAppendix 4C - quarterly
18/04/13PRICE SENSITIVE
MGZAppendix 3Y
11/04/13
MGZChange of Director's Interest Notice
27/03/13
MGZHalf Yearly Report and Accounts
28/02/13PRICE SENSITIVE
MGZAppendix 4C - quarterly
10/01/13PRICE SENSITIVE
MGZResults of Meeting
30/11/12
MGZChairman's Address to Shareholders
30/11/12
MGZAnnual Report to shareholders
30/10/12
MGZNotice of Annual General Meeting/Proxy Form
30/10/12
MGZAppendix 4C - quarterly
29/10/12PRICE SENSITIVE
MGZMedigard announces Heads of Agreement
24/10/12PRICE SENSITIVE
MGZFull Year Statutory Accounts
13/09/12
MGZPreliminary Final Report
28/08/12PRICE SENSITIVE
MGZAppendix 4C - quarterly
30/07/12PRICE SENSITIVE
MGZAppendix 4C - quarterly
30/04/12PRICE SENSITIVE
MGZHalf Yearly Report and Accounts
29/02/12PRICE SENSITIVE
MGZAppendix 4C - quarterly
30/01/12PRICE SENSITIVE
MGZResults of Meeting
21/11/11
MGZChairman's Address to Shareholders
21/11/11
MGZAppendix 4C - quarterly
25/10/11PRICE SENSITIVE
MGZNotice of Annual General Meeting/Proxy Form
21/10/11
MGZAnnual Report to shareholders
21/10/11
MGZAnnual Report to shareholders
28/09/11
MGZPreliminary Final Report
31/08/11PRICE SENSITIVE
MGZAppendix 4C - quarterly
29/07/11PRICE SENSITIVE
MGZExpiry of Options
03/06/11
MGZAppendix 4C - 31 March 2011
29/04/11PRICE SENSITIVE
MGZResignation as Executive of Medigard
18/04/11
MGZCompany Secretary Appointment/Resignation
23/03/11
MGZAppendix 3B
02/03/11
MGZNotice of Resignation CEO and Company Secretary
24/02/11PRICE SENSITIVE
MGZHalf Yearly Report and Accounts
24/02/11PRICE SENSITIVE
MGZBoardroom Radio Broadcast
02/02/11
MGZGrant of Japanese Patent (BCD) and IPRP (1mL Syringe)
01/02/11PRICE SENSITIVE
MGZAppendix 4C - quarterly
28/01/11PRICE SENSITIVE
MGZUpdated Trading Policy
31/12/10
MGZMEDIGARD CHANGE OF ADDRESS
20/12/10
MGZTrading Policy
07/12/10
MGZBoardroom Radio Broadcast
24/11/10
MGZResults of Meeting
24/11/10
MGZChairman's Address to Shareholders
23/11/10
MGZChange of Director's Interest Notice
16/11/10
MGZAppendix 3B
16/11/10
MGZAppendix 4C - quarterly
28/10/10PRICE SENSITIVE
MGZAppendix 3B
19/10/10
MGZNotice of Annual General Meeting/Proxy Form
13/10/10
MGZAnnual Report to shareholders
30/09/10
MGZGrant of Patent in South Africa
21/09/10PRICE SENSITIVE
MGZAppendix 3B
13/09/10
MGZChange of Director's Interest Notice
02/09/10
MGZChange of Director's Interest Notice
02/09/10
MGZPreliminary Final Report
31/08/10PRICE SENSITIVE
MGZCompletion Renounceable Rights Issue and Appendix 3B
30/08/10
MGZBoardroom Radio Broadcast
20/08/10
MGZBroker Presentation
17/08/10
MGZInvestor Presentations
12/08/10
MGZDespatch of Prospectus and Letter to Shareholders
10/08/10
MGZLetter to Shareholders
09/08/10
MGZSupplementary Prospectus
06/08/10
MGZMarket Announcement
05/08/10PRICE SENSITIVE
MGZBoardroom Radio Broadcast
03/08/10
MGZAppendix 4C - quarterly
29/07/10PRICE SENSITIVE
MGZLetter to Shareholders
28/07/10
MGZRevised Indicative Timetable for Renounceable Rights Issue
27/07/10
MGZProspectus
27/07/10PRICE SENSITIVE
MGZRenounceable Issue
27/07/10PRICE SENSITIVE
MGZLetter to Shareholders
28/05/10
MGZSigning of US Manufacturing and Distribution Agreements
26/05/10PRICE SENSITIVE
MGZTrading Halt
25/05/10PRICE SENSITIVE
MGZAppendix 4C - quarterly
16/04/10PRICE SENSITIVE
MGZAppendix 3B
08/04/10
MGZClinical Trial Results USA - Medigard Syringe
06/04/10PRICE SENSITIVE
MGZAppendix 3B
26/03/10
MGZReplacement and Updated Appendix 3B
25/03/10
MGZMarketing and Product Evaluation USA
24/03/10PRICE SENSITIVE
MGZAppendix 3B
16/03/10
MGZAppendix 3B
26/02/10
MGZHalf Yearly Report and Accounts
26/02/10PRICE SENSITIVE
MGZChange of Director's Interest Notice
12/02/10
MGZAppendix 4C - quarterly
25/01/10PRICE SENSITIVE
MGZMedigard Signs US Manufacturer
11/12/09PRICE SENSITIVE
MGZResults of Meeting
26/11/09
MGZChairman's Address to Shareholders
25/11/09
refresh Created with Sketch. REFRESH
 

Top Stories

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s. 
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025 Samples among the highest-ever-graded uranium soil samples recorded in mineral exploration history, and an imminent drill run.
Breaking news: New opportunities for investors & companies - HotCopper opens to capital raising! Companies can now raise capital through HotCopper! It’s a development allowing a highly cost-effective service to ASX-listed companies, while opening new investment opportunities to investors.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.